29 results
Keyword paxlovid Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Paxlovid (updated)
nirmatrelvir, ritonavir, COVID-19 virus infection
Date of authorisation: 28/01/2022, Revision: 13, Authorised, Last updated: 21/09/2023Paxlovid Pneumonia, Viral Respiratory … nirmatrelvirritonavir Overview Paxlovid is a medicine used for treating … disease becoming severe. Paxlovid contains two The substance … -
List item
COVID-19 medicines (updated)
Last updated: 15/09/2023granted: 17/12/2021 Latest news Paxlovid (PF-07321332 / ritonavir …
-
List item
Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)
Single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 06/01/2021,
, 
, Revision: 40, Authorised, Last updated: 14/09/2023
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, , Revision: 44, Authorised, Last updated: 11/09/2023
-
List item
Human medicine European public assessment report (EPAR): Bimervax (updated)
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains, COVID-19 virus infection
Date of authorisation: 30/03/2023,, Revision: 2, Authorised, Last updated: 01/09/2023
-
List item
Human medicine European public assessment report (EPAR): Nuvaxovid (updated)
SARS-CoV-2 recombinant spike protein, COVID-19 virus infection
Date of authorisation: 20/12/2021,, Revision: 10, Authorised, Last updated: 24/08/2023
-
List item
Human medicine European public assessment report (EPAR): Evusheld
tixagevimab, cilgavimab, COVID-19 virus infection
Date of authorisation: 25/03/2022,, Revision: 3, Authorised, Last updated: 18/08/2023
-
List item
Safety of COVID-19 vaccines
Last updated: 14/08/2023 -
List item
Human medicine European public assessment report (EPAR): Ronapreve
casirivimab, imdevimab, COVID-19 virus infection
Date of authorisation: 12/11/2021,, Revision: 5, Authorised, Last updated: 10/07/2023
-
List item
Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, Revision: 30, Authorised, Last updated: 04/07/2023
-
List item
COVID-19 medicines: Article 18 and Article 5(3) reviews
Last updated: 06/06/2023Treatment Status More information Paxlovid (PF-07321332 / ritonavir … EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir …
-
List item
COVID-19: latest updates (archive)
Last updated: 05/06/2023marketing authorisation for Paxlovid to standard The approval to … States. marketing authorisation Paxlovid 26/01/2023 EMA published … information for COVID-19 treatment Paxlovid, with an increase in its approved …
-
List item
Availability of medicines during COVID-19
Last updated: 19/04/2023 -
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva
SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020, COVID-19 virus infection
Date of authorisation: 24/06/2022,, Revision: 6, Authorised, Last updated: 04/04/2023
-
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022Antiviral treatments such as Paxlovid (nirmatrelvir / ritonavir … treating COVID-19, including Paxlovid and Veklury, is available … Nirmatrelvir/Ritonavir (Paxlovid)15 and Remdesivir (Veklury)16 … -
List item
Human medicine European public assessment report (EPAR): VidPrevtyn Beta
SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain), COVID-19 virus infection
Date of authorisation: 10/11/2022,, Authorised, Last updated: 30/11/2022
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022Paxlovid … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022marketing authorisation for Paxlovid … marketing authorisation for Paxlovid … THE MEDICINAL PRODUCT Paxlovid 150 mg + 100 mg film-coated … -
List item
News: EMA receives application for conditional marketing authorisation for Paxlovid (PF-07321332 and ritonavir) for treating patients with COVID-19
CHMP, PRAC, Last updated: 10/01/2022marketing authorisation for Paxlovid (PF-07321332 and ritonavir … marketing authorisation for Paxlovid (PF-07321332 and ritonavir … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021
CHMP, Last updated: 17/12/2021COVID-19: Advice on use of Paxlovid for treating COVID-19 The … -
List item
News: EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: rolling review starts in parallel
CHMP, Last updated: 16/12/2021EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir … EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir … -
List item
Public stakeholder meeting on COVID-19 vaccines and therapeutics in the EU
Online, 13:00 - 15:15 Amsterdam time (CET), 25/11/2021, Last updated: 25/11/2021 -
List item
News: EMA starts review of Paxlovid for treating patients with COVID-19
CHMP, Last updated: 19/11/2021EMA starts review of Paxlovid for treating patients with … EMA starts review of Paxlovid for treating patients with …